AmyBickleman.bsky.social
@amybickleman.bsky.social
Nonprofit Executive Director, animal lover, league bowler and traveling adventurer
Reposted by AmyBickleman.bsky.social
New video series with Dr. Siddharth Sheth, John Kaczmar, and @AriRosenbergMD .
Recorded 27 Oct 2025 — diving into fresh data & breakthrough developments in head & neck cancer. Clear, concise & highly relevant.
▶ www.youtube.com/watch?v=d5sl...
#Oncology #CancerResearch #HeadAndNeckCancer
Recorded 27 Oct 2025 — diving into fresh data & breakthrough developments in head & neck cancer. Clear, concise & highly relevant.
▶ www.youtube.com/watch?v=d5sl...
#Oncology #CancerResearch #HeadAndNeckCancer
November 24, 2025 at 8:23 PM
New video series with Dr. Siddharth Sheth, John Kaczmar, and @AriRosenbergMD .
Recorded 27 Oct 2025 — diving into fresh data & breakthrough developments in head & neck cancer. Clear, concise & highly relevant.
▶ www.youtube.com/watch?v=d5sl...
#Oncology #CancerResearch #HeadAndNeckCancer
Recorded 27 Oct 2025 — diving into fresh data & breakthrough developments in head & neck cancer. Clear, concise & highly relevant.
▶ www.youtube.com/watch?v=d5sl...
#Oncology #CancerResearch #HeadAndNeckCancer
Reposted by AmyBickleman.bsky.social
It's Clinical Trials Day! Today, we celebrate the incredible power of clinical trials in advancing cancer care. These trials are essential for discovering new treatments and improving lives.+
May 20, 2025 at 6:18 PM
It's Clinical Trials Day! Today, we celebrate the incredible power of clinical trials in advancing cancer care. These trials are essential for discovering new treatments and improving lives.+
Reposted by AmyBickleman.bsky.social
Lyudmila Bazhenova, MD, is a board-certified medical oncologist and a professor of medicine at UC San Diego Moores Cancer Center. She currently leads the lung cancer group at UC San Diego and has over 20 years of experience in managing patients with lung cancer. +
March 10, 2025 at 8:22 PM
Lyudmila Bazhenova, MD, is a board-certified medical oncologist and a professor of medicine at UC San Diego Moores Cancer Center. She currently leads the lung cancer group at UC San Diego and has over 20 years of experience in managing patients with lung cancer. +
Reposted by AmyBickleman.bsky.social
@DrKarenYunMD is an Assistant Clinical Professor at UC San Diego Moores Cancer Center and medical oncologist who treats adults with head, neck and lung cancers.
Prior to joining UC San Diego Health in 2023, Dr. Yun completed her hematology-oncology fellowship and internal medicine residency+
Prior to joining UC San Diego Health in 2023, Dr. Yun completed her hematology-oncology fellowship and internal medicine residency+
March 7, 2025 at 5:46 PM
@DrKarenYunMD is an Assistant Clinical Professor at UC San Diego Moores Cancer Center and medical oncologist who treats adults with head, neck and lung cancers.
Prior to joining UC San Diego Health in 2023, Dr. Yun completed her hematology-oncology fellowship and internal medicine residency+
Prior to joining UC San Diego Health in 2023, Dr. Yun completed her hematology-oncology fellowship and internal medicine residency+
Reposted by AmyBickleman.bsky.social
Do you have a passion for patient education?
GRACE is looking for oncology fellows and finishing fellows with a particular interest and passion for communications and patient education, and for those who are simply looking for a way to give back to the oncology community. +
GRACE is looking for oncology fellows and finishing fellows with a particular interest and passion for communications and patient education, and for those who are simply looking for a way to give back to the oncology community. +
February 28, 2025 at 11:47 PM
Do you have a passion for patient education?
GRACE is looking for oncology fellows and finishing fellows with a particular interest and passion for communications and patient education, and for those who are simply looking for a way to give back to the oncology community. +
GRACE is looking for oncology fellows and finishing fellows with a particular interest and passion for communications and patient education, and for those who are simply looking for a way to give back to the oncology community. +
Reposted by AmyBickleman.bsky.social
Ideal candidates should have strong written and oral communication skills as well as a proven ability to stay abreast of the latest advances in cancer medicine.
Apply now and become a contributor in your field!
Applications close March 31, 2025.
Click here to apply: cancergrace.org/post/2025-pa...
Apply now and become a contributor in your field!
Applications close March 31, 2025.
Click here to apply: cancergrace.org/post/2025-pa...
2025 Patient Education Ambassadors Program | CancerGRACE
Patient Education Ambassadors Program 2025 Program Information Form and Application
cancergrace.org
February 27, 2025 at 8:20 PM
Ideal candidates should have strong written and oral communication skills as well as a proven ability to stay abreast of the latest advances in cancer medicine.
Apply now and become a contributor in your field!
Applications close March 31, 2025.
Click here to apply: cancergrace.org/post/2025-pa...
Apply now and become a contributor in your field!
Applications close March 31, 2025.
Click here to apply: cancergrace.org/post/2025-pa...
Reposted by AmyBickleman.bsky.social
This January, #BeAware about cervical cancer.
Early detection saves lives: Regular screenings (like Pap tests and HPV tests) are crucial.
Prevention is key: The HPV vaccine is highly effective in preventing cervical cancer.+
Early detection saves lives: Regular screenings (like Pap tests and HPV tests) are crucial.
Prevention is key: The HPV vaccine is highly effective in preventing cervical cancer.+
January 8, 2025 at 7:03 PM
This January, #BeAware about cervical cancer.
Early detection saves lives: Regular screenings (like Pap tests and HPV tests) are crucial.
Prevention is key: The HPV vaccine is highly effective in preventing cervical cancer.+
Early detection saves lives: Regular screenings (like Pap tests and HPV tests) are crucial.
Prevention is key: The HPV vaccine is highly effective in preventing cervical cancer.+
Reposted by AmyBickleman.bsky.social
Wishing you a year filled with strength, hope, and the knowledge that you are not alone in the fight against cancer.
Happy New Year 2025!
Happy New Year 2025!
December 31, 2024 at 6:13 PM
Wishing you a year filled with strength, hope, and the knowledge that you are not alone in the fight against cancer.
Happy New Year 2025!
Happy New Year 2025!
Reposted by AmyBickleman.bsky.social
May the spirit of the season fill your heart with hope and strength. Wishing you a Merry Christmas filled with courage and joy.
Merry Christmas from the GRACE team to you!
Merry Christmas from the GRACE team to you!
December 23, 2024 at 7:38 PM
May the spirit of the season fill your heart with hope and strength. Wishing you a Merry Christmas filled with courage and joy.
Merry Christmas from the GRACE team to you!
Merry Christmas from the GRACE team to you!
Reposted by AmyBickleman.bsky.social
This live, virtual, interactive patient education event included presentations and panel discussions on subjects relevant to a diverse range of lung cancers and treatment options, and an opportunity to ask questions of the experts.+
December 19, 2024 at 5:45 PM
This live, virtual, interactive patient education event included presentations and panel discussions on subjects relevant to a diverse range of lung cancers and treatment options, and an opportunity to ask questions of the experts.+
Reposted by AmyBickleman.bsky.social
December 14, 2024 at 5:56 PM
Reposted by AmyBickleman.bsky.social
We are live at our Lung Cancer OncTalk 2024!
Dr. Misty Dawn Shields presenting Small Cell Lung Cancer: Advancements, Approvals, and a Look Ahead.
Join us now!
#LungCancer #SCLC
Dr. Misty Dawn Shields presenting Small Cell Lung Cancer: Advancements, Approvals, and a Look Ahead.
Join us now!
#LungCancer #SCLC
December 14, 2024 at 4:14 PM
We are live at our Lung Cancer OncTalk 2024!
Dr. Misty Dawn Shields presenting Small Cell Lung Cancer: Advancements, Approvals, and a Look Ahead.
Join us now!
#LungCancer #SCLC
Dr. Misty Dawn Shields presenting Small Cell Lung Cancer: Advancements, Approvals, and a Look Ahead.
Join us now!
#LungCancer #SCLC
Reposted by AmyBickleman.bsky.social
Q&A session with Drs. @alissajcooper, @drshieldsmd, and @IbiayiMD.
With the development of incorporating immunotherapy in limited-stage SCLC, Where does brain radiation stand?
#SCLC #LungCancer #BrainRadiation
With the development of incorporating immunotherapy in limited-stage SCLC, Where does brain radiation stand?
#SCLC #LungCancer #BrainRadiation
December 14, 2024 at 5:05 PM
Q&A session with Drs. @alissajcooper, @drshieldsmd, and @IbiayiMD.
With the development of incorporating immunotherapy in limited-stage SCLC, Where does brain radiation stand?
#SCLC #LungCancer #BrainRadiation
With the development of incorporating immunotherapy in limited-stage SCLC, Where does brain radiation stand?
#SCLC #LungCancer #BrainRadiation
Reposted by AmyBickleman.bsky.social
Osimertinib Monotherapy (The FLAURA clinical trial):
Both progression-free and overall survival were longer with Osimertinib than with first-generation EGFR TKIs.
@JuliaRotow
#LungCancer #Osimertinib #EGFR #TKIs #TheFlauraClinicalTrial
Both progression-free and overall survival were longer with Osimertinib than with first-generation EGFR TKIs.
@JuliaRotow
#LungCancer #Osimertinib #EGFR #TKIs #TheFlauraClinicalTrial
December 14, 2024 at 5:18 PM
Osimertinib Monotherapy (The FLAURA clinical trial):
Both progression-free and overall survival were longer with Osimertinib than with first-generation EGFR TKIs.
@JuliaRotow
#LungCancer #Osimertinib #EGFR #TKIs #TheFlauraClinicalTrial
Both progression-free and overall survival were longer with Osimertinib than with first-generation EGFR TKIs.
@JuliaRotow
#LungCancer #Osimertinib #EGFR #TKIs #TheFlauraClinicalTrial
Reposted by AmyBickleman.bsky.social
EGFR mutations are the most common actionable mutations in lung cancer, found in ~15% of cases.
On average, people with EGFR lung cancer are:
- Younger at diagnosis.
- More likely to be women.
- More likely to have Asian Ancestry.
- Less likely to have a history of heavy tobacco use. +
On average, people with EGFR lung cancer are:
- Younger at diagnosis.
- More likely to be women.
- More likely to have Asian Ancestry.
- Less likely to have a history of heavy tobacco use. +
December 10, 2024 at 1:57 PM
EGFR mutations are the most common actionable mutations in lung cancer, found in ~15% of cases.
On average, people with EGFR lung cancer are:
- Younger at diagnosis.
- More likely to be women.
- More likely to have Asian Ancestry.
- Less likely to have a history of heavy tobacco use. +
On average, people with EGFR lung cancer are:
- Younger at diagnosis.
- More likely to be women.
- More likely to have Asian Ancestry.
- Less likely to have a history of heavy tobacco use. +
Reposted by AmyBickleman.bsky.social
Dr. Angel Qin is an Associate Professor at the University of Michigan Rogel Cancer Center. Her research interests include mechanisms of resistance to treatment and targeted therapies.+
November 21, 2024 at 5:59 PM
Dr. Angel Qin is an Associate Professor at the University of Michigan Rogel Cancer Center. Her research interests include mechanisms of resistance to treatment and targeted therapies.+
Reposted by AmyBickleman.bsky.social
Let's count our blessings as we gather with loved ones this Thanksgiving. We’re grateful for the strength of families, the power of hope, and the unwavering spirit of a strong and united advocates community for patients with cancer and their families.
Happy Thanksgiving!
#Thanksgiving #Family #Hope
Happy Thanksgiving!
#Thanksgiving #Family #Hope
November 28, 2024 at 2:05 PM
Let's count our blessings as we gather with loved ones this Thanksgiving. We’re grateful for the strength of families, the power of hope, and the unwavering spirit of a strong and united advocates community for patients with cancer and their families.
Happy Thanksgiving!
#Thanksgiving #Family #Hope
Happy Thanksgiving!
#Thanksgiving #Family #Hope
Reposted by AmyBickleman.bsky.social
Q&A: What is Risk Stratification and What Does it Mean for Treatment? - 2024 Blood Cancer OncTalk youtu.be/iXE1yDlmNnE?... via @YouTube
In this video, the panel discusses what a risk stratification score is and what it means for blood cancer treatment.
For more, please visit cancergrace.org.
In this video, the panel discusses what a risk stratification score is and what it means for blood cancer treatment.
For more, please visit cancergrace.org.
Q&A: What is Risk Stratification and What Does it Mean for Treatment? - 2024 Blood Cancer OncTalk
YouTube video by GRACE - Global Resource for Advancing Cancer Education
youtu.be
November 27, 2024 at 7:45 PM
Q&A: What is Risk Stratification and What Does it Mean for Treatment? - 2024 Blood Cancer OncTalk youtu.be/iXE1yDlmNnE?... via @YouTube
In this video, the panel discusses what a risk stratification score is and what it means for blood cancer treatment.
For more, please visit cancergrace.org.
In this video, the panel discusses what a risk stratification score is and what it means for blood cancer treatment.
For more, please visit cancergrace.org.
Reposted by AmyBickleman.bsky.social
The Lung Cancer OncTalk 2024 is a live, virtual, interactive patient education event that includes presentations and panel discussions covering general subjects relevant to lung cancer and treatment options, as well as an opportunity to speak with the experts in a Q&A session.+
November 22, 2024 at 7:16 PM
The Lung Cancer OncTalk 2024 is a live, virtual, interactive patient education event that includes presentations and panel discussions covering general subjects relevant to lung cancer and treatment options, as well as an opportunity to speak with the experts in a Q&A session.+
Reposted by AmyBickleman.bsky.social
Have you experienced a rash as a result of taking an EGFR inhibitor? If so, GRACE is inviting you to participate in a brief, scripted interview in collaboration with our partner, Prova Education, to help develop patient education materials to help other patients with this same side effect.+
November 21, 2024 at 12:15 AM
Have you experienced a rash as a result of taking an EGFR inhibitor? If so, GRACE is inviting you to participate in a brief, scripted interview in collaboration with our partner, Prova Education, to help develop patient education materials to help other patients with this same side effect.+
Reposted by AmyBickleman.bsky.social
Are you a patient with lung cancer? Please help us improve patient resources by taking a short survey. Your feedback matters!+
November 14, 2024 at 10:44 PM
Are you a patient with lung cancer? Please help us improve patient resources by taking a short survey. Your feedback matters!+
Reposted by AmyBickleman.bsky.social
This April, Know Your Neck! #HeadAndNeckCancerAwareness Head and Neck Cancer is more common than you might think.
Early detection is key! Be aware of the signs and symptoms: ➡ Lump in the neck
➡ Mouth sore that won't heal
➡ Hoarseness
➡ Difficulty swallowing
+
Early detection is key! Be aware of the signs and symptoms: ➡ Lump in the neck
➡ Mouth sore that won't heal
➡ Hoarseness
➡ Difficulty swallowing
+
April 18, 2024 at 4:47 PM
This April, Know Your Neck! #HeadAndNeckCancerAwareness Head and Neck Cancer is more common than you might think.
Early detection is key! Be aware of the signs and symptoms: ➡ Lump in the neck
➡ Mouth sore that won't heal
➡ Hoarseness
➡ Difficulty swallowing
+
Early detection is key! Be aware of the signs and symptoms: ➡ Lump in the neck
➡ Mouth sore that won't heal
➡ Hoarseness
➡ Difficulty swallowing
+
Reposted by AmyBickleman.bsky.social
Lowering Your Breast Cancer Risk - The Importance of Testing 2023 youtu.be/c3rniloe9Kg?... via @YouTube
In this video, Dr. Doug Micalizzi discusses what individuals can do to lower their risk of developing breast cancer.
In this video, Dr. Doug Micalizzi discusses what individuals can do to lower their risk of developing breast cancer.
March 18, 2024 at 11:11 PM
Lowering Your Breast Cancer Risk - The Importance of Testing 2023 youtu.be/c3rniloe9Kg?... via @YouTube
In this video, Dr. Doug Micalizzi discusses what individuals can do to lower their risk of developing breast cancer.
In this video, Dr. Doug Micalizzi discusses what individuals can do to lower their risk of developing breast cancer.
Reposted by AmyBickleman.bsky.social
In November 2023, the (FDA) approved repotrectinib (Augtyro) for the treatment of some advanced lung cancers that have a genetic change called a ROS1 gene fusion.
The complete results of the clinical trial that led to the approval have been published.
www.cancer.gov/news-events/...
The complete results of the clinical trial that led to the approval have been published.
www.cancer.gov/news-events/...
March 8, 2024 at 11:55 PM
In November 2023, the (FDA) approved repotrectinib (Augtyro) for the treatment of some advanced lung cancers that have a genetic change called a ROS1 gene fusion.
The complete results of the clinical trial that led to the approval have been published.
www.cancer.gov/news-events/...
The complete results of the clinical trial that led to the approval have been published.
www.cancer.gov/news-events/...
Reposted by AmyBickleman.bsky.social
We are looking for oncology fellows and finishing fellows with a particular interest and passion for communications, and patient education, and for those who are simply looking for a way to give back to the oncology community.
Click here to apply: cancergrace.org/post/2024-pa...
Click here to apply: cancergrace.org/post/2024-pa...
February 17, 2024 at 3:48 AM
We are looking for oncology fellows and finishing fellows with a particular interest and passion for communications, and patient education, and for those who are simply looking for a way to give back to the oncology community.
Click here to apply: cancergrace.org/post/2024-pa...
Click here to apply: cancergrace.org/post/2024-pa...